2019
Syntaphilin Is a Novel Biphasic Biomarker of Aggressive Prostate Cancer and a Metastasis Predictor
Hwang MJ, Bryant KG, Seo JH, Liu Q, Humphrey PA, Melnick MAC, Altieri DC, Robert ME. Syntaphilin Is a Novel Biphasic Biomarker of Aggressive Prostate Cancer and a Metastasis Predictor. American Journal Of Pathology 2019, 189: 1180-1189. PMID: 31079810, PMCID: PMC6560381, DOI: 10.1016/j.ajpath.2019.02.009.Peer-Reviewed Original ResearchConceptsProstate cancerTumor bulkInvasive frontHigh Gleason grade prostate cancerLocalized prostate cancerGrade prostate cancerAggressive prostate cancerCell proliferationKi-67 labelingTumor cell proliferationMetastasis predictorMetastatic diseaseDistant metastasisGleason gradeAccessible biomarkersProstate tumorsMetastatic potentialNovel markerCancerBiphasic patternProliferative rateHigh expressionOxidative metabolismReduced levelsTumors
2005
Squamous Cell Carcinoma of the Pancreas
Brown H, Dotto J, Robert M, Salem R. Squamous Cell Carcinoma of the Pancreas. Journal Of Clinical Gastroenterology 2005, 39: 915-919. PMID: 16208119, DOI: 10.1097/01.mcg.0000180636.74387.e6.Peer-Reviewed Original ResearchConceptsSquamous cell carcinomaCell carcinomaMetastatic diseaseEvidence of metastatic diseasePancreatic ductal epitheliumNegative marginsRare tumorSurgical resectionPancreatic malignancyBack painBloc resectionLymph nodesRare conditionPoor prognosisDuctal epitheliumCarcinomaResectionPancreasDiseaseMalignancyLymphPainPrognosisTumorEpithelium